Liver graft outcomes from donors with vaccine induced thrombosis and thrombocytopenia (VITT): United Kingdom multicenter experience

Angus Hann, Hermien Hartog, Anisa Nutu, Katherine Quist, Rebecca Sanabria-Mateos, George H.B. Greenhall, Ines Ushiro-Lumb, Phillip L.R. Nicolson, Owen Cain, Ye H. Oo, Abhishek Chauhan, Will Lester, Joerg Matthias Pollok, Andreas Prachalias, John R. Isaac, Douglas Thorburn, John Forsythe, Khalid Sharif, Desley A.H. Neil, Darius F. MirzaM. Thamara P.R. Perera*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalAmerican Journal of Transplantation
DOIs
Publication statusAccepted/In press - 2021
Externally publishedYes

Bibliographical note

Funding Information:
Mr. Chris Callaghan, associate medical director NHSBT, United Kingdom for the support and contribution in data collection. Prof Ye H Oo receives funding from the Sir Jules Thorn Biomedical Research Charity. Dr Angus Hann’s program of research is partly funded by the Catherine Marie Enright Kelly memorial research scholarship from the Royal Australasian College of Surgeons. Manuscript figures created with biorender.com.

Keywords

  • alloantibody
  • autoimmunity
  • clinical research/practice
  • donors and donation: donor evaluation
  • ethics and public policy
  • liver allograft function/dysfunction
  • liver transplantation/hepatology
  • organ procurement and allocation
  • pathology/histopathology
  • vaccine

Cite this